Medlive Technology Co., Ltd. (Stock Code: 02192) published its monthly return for the period ended 30 November 2025. The authorized share capital remained at 50,000,000,000 ordinary shares, each valued at USD 0.00001, maintaining a total authorized share capital of USD 500,000.
The total issued shares likewise stood at 734,793,375, showing no movements during the reporting period. Under the Pre-IPO Share Option Scheme, 5,481,125 share options remained outstanding; no new shares were issued, and the Post-IPO Share Option Scheme indicated that 69,017,600 shares may be issued upon exercise of granted options.
The company confirmed compliance with relevant listing rules and regulations. No other changes in treasury shares or warrant-related movements were announced for November 2025.